Skip to Content
Last Updated: 04/25/2012

Current Funding Opportunities

Program Announcements where CTEP
is a Secondary Contact

Number Title
PA-12-013 Validation of Molecular Diagnostics to Predict Patient Outcomes Using Specimens from Multi-Site Cancer Trials (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-12-013.html#_Section_VII._Agency
PA-08-267 Exploratory Studies in Cancer Detection, Diagnosis and Prognosis (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-08-267.html
PA-11-297 Pilot Studies in Pancreatic Cancer (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-11-297.html
PA-11-298 Pilot Studies in Pancreatic Cancer (R03)
http://grants.nih.gov/grants/guide/pa-files/PA-11-298.html
PA-11-057 Developmental Pharmacology (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-11-057.html
PA-11-059 Developmental Pharmacology (R21)
http://grants1.nih.gov/grants/guide/pa-files/PAR-11-059.html
PA-11-058 Developmental Pharmacology (R03)
http://grants1.nih.gov/grants/guide/pa-files/PAR-11-058.html

About the
Associate Director

Jeffrey S. Abrams, M.D. Jeffrey S. Abrams, M.D., has led the Cancer Therapy Evaluation Program (CTEP) since June 2007.  Dr. Abrams came to CTEP in 1993 when he joined as a clinical research scientist to oversee the breast cancer treatment trials portfolio and participate in clinical trials at the NIH Clinical Center and the National Naval Medical Center. More…

For More Details
About CTEP